| Jul 26 |
FDA issues warning on compounded versions of Novo Nordisk's semaglutide
|
| Jul 26 |
How Is The Market Feeling About Hims & Hers Health?
|
| Jul 22 |
Why Hims & Hers Heath Shares Are Surging Today
|
| Jul 22 |
Hims & Hers appoints former Novo Nordisk president to board
|
| Jul 22 |
Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board
|
| Jul 21 |
Hims & Hers Health: Expecting A Healthy Report
|
| Jul 19 |
Hims & Hers Health: Built On Successful Branding
|
| Jul 18 |
Hims & Hers: The Thesis Goes Far Beyond GLP-1
|
| Jul 16 |
Should You Keep Chemed Stock in Your Portfolio Now?
|
| Jul 15 |
Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024
|
